Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled time : 15:15 save search
LAVA Therapeutics and The Antibody Society Present Emerging Cancer Therapies Virtual Symposium
Published: 2021-11-11 (Crawled : 15:15) - globenewswire.com
LVTX | $2.85 -3.06% -3.16% 100K
|
|
| O: 0.02%
H: 2.66%
C: 1.92%
cancer antibody therapy symposium
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Cancer Specialist During 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-09 (Crawled : 15:15) - biospace.com/
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: -0.96%
H: 1.24%
C: -4.76%
immunotherapy therapy cancer conference
Decibel Therapeutics to Present at the Barclays Gene Editing & Gene Therapy Summit
Published: 2021-11-08 (Crawled : 15:15) - biospace.com/
DBTX | $4.91 -0.81% -0.2% 0
|
Health Technology
|
| O: -1.07%
H: 2.71%
C: -10.36%
gene therapy therapy
Athletico Physical Therapy Appoints Michelle Millstone-Shroff to Board of Directors
Published: 2021-10-15 (Crawled : 15:15) - prnewswire.com
PSA | $260.28 -0.58% 0.0% 750K
|
Finance
|
| O: 0.3%
H: 0.06%
C: -2.28%
therapy
The Truth About Magnet Therapy, AKA TMS Therapy
Published: 2021-09-30 (Crawled : 15:15) - brainsway.com
BWAY | $4.8 -4.95% -5.21% 80K
|
Health Technology
|
| O: -0.12%
H: 0.73%
C: -1.47%
therapy
FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals
Published: 2021-09-02 (Crawled : 15:15) - fda.gov
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
fda therapy drug approval fda ide milestone
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ATI Physical Therapy f/k/a Fortress Value Acquisition Corp. II and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Published: 2021-08-31 (Crawled : 15:15) - prnewswire.com
ATIP 4 | $4.06 -2.64% 0.99% 2.1K
|
Manufacturing
|
| O: 0.0%
H: 3.86%
C: 3.61%
acquisition therapy acquisition corp
Global Cancer Therapies Market to Reach $204.2 Billion by 2024
Published: 2021-08-05 (Crawled : 15:15) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.61%
C: 0.55%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.42%
H: 0.31%
C: 0.13%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -0.09%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.69%
H: 0.37%
C: 0.34%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.31%
H: 0.85%
C: 0.35%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.26%
H: 0.13%
C: -0.36%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 1.48%
H: 0.46%
C: 0.43%
cancer therapy
Biologics Market Size to Reach USD 477.15 Billion in 2027 | Rapid Advancements in Molecular Therapy and Cell-Based Biologics, Increasing Incidence of Chronic Diseases, are Some Key Factors Driving Industry Growth, says Emergen Research
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
disease therapy molecular growth research merge
Raging Demand for Minimal Invasive Surgical Procedures Driving Laser Therapy Devices Market: Future Market Insights
Published: 2021-05-27 (Crawled : 15:15) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: -0.0%
H: 2.82%
C: 2.79%
DHR | $236.36 -1.27% 0.0% 4.2M
|
Health Technology
|
| O: 0.05%
H: 1.49%
C: 1.32%
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: 0.53%
H: 0.43%
C: -0.21%
IPGP | $84.61 0.28% 0.28% 160K
|
Electronic Technology
|
| O: -0.65%
H: 1.73%
C: 0.28%
laser therapy device market
Dyne Therapeutics Presents New Preclinical Data from its Myotonic Dystrophy Type 1 Program During American Society of Gene & Cell Therapy Annual Meeting Demonstrating Sustained Knockdown of Toxic Human Nuclear DMPK RNA
Published: 2021-05-14 (Crawled : 15:15) - biospace.com/
DYN | $23.65 -4.71% -4.95% 980K
|
Health Technology
|
| O: 1.59%
H: 3.83%
C: 1.28%
therapy preclinical pre-clinical
REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at American Society of Gene and Cell Therapy's 24th Annual Meeting
Published: 2021-05-14 (Crawled : 15:15) - biospace.com/
RGNX | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: 1.47%
H: 2.68%
C: 0.92%
treatment positive therapy trial syndros mps-ih
Vertex and CRISPR Therapeutics to Present New Clinical Data on Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ For Severe Hemoglobinopathies at the Annual European Hematology Association Virtual Congress
Published: 2021-05-12 (Crawled : 15:15) - globenewswire.com
VRTX | News | $393.51 0.1% 0.1% 950K
|
Health Technology
|
| O: -0.44%
H: 1.7%
C: 0.29%
CRSP M | $56.14 1.04% 1.03% 1.7M
|
Health Technology
|
| O: -2.06%
H: 2.89%
C: -0.56%
crispr europe therapy ctx001
P-BCMA-ALLO1 — A Fully Allogeneic Stem Cell Memory T Cell (TSCM) CAR-T Therapy Targeting BCMA for the Treatment of Multiple Myeloma Shows Potent Anti-Tumor Activity
Published: 2021-05-11 (Crawled : 15:15) - poseida.com
PSTX | News | $2.005 -1.72% -1.75% 520K
|
Health Technology
|
| O: -0.13%
H: 8.68%
C: 6.92%
treatment stem cell therapy car-t t-cell
UPDATE - Advaxis Announces Achievement of Second Milestone Under ADXS-HER2 Licensing Agreement with OS Therapies
Published: 2021-04-26 (Crawled : 15:15) - globenewswire.com
ADXS | $0.6455 12.48% 2.3K
|
Health Technology
|
| O: 5.39%
H: 2.78%
C: 0.67%
license therapy her2+ milestone her2- her2
Global Immuno-Oncology Market Report 2021: IO Therapies Achieved Sales of ~$30B in 2019 and is Projected to Reach ~$95B by 2026
Published: 2021-03-30 (Crawled : 15:15) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.71%
H: 0.04%
C: -0.34%
sales therapy
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.